Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
BMC Research Notes
|
July 5, 2015
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods
Aurélie Bourmaud, Emilie Henin, Fabien Tinquaut, et al.
Cancer Chemotherapy and Pharmacology
|
January 8, 2022
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
Manon Reda, Pauline Macaire, Hélène Bellio, et al.
Gynecologic Oncology
|
February 6, 2026
Eco-responsible and rational interval debulking surgery for high-grade ovarian carcinomas: An observational, ambispective cohort study
Sarah Hodent, Naoual Bakrin, Pascal Rousset, et al.
Cancer Chemotherapy and Pharmacology
|
April 3, 2023
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial
Alicja Puszkiel, Benoit You, Léa Payen, et al.
Cancers
|
January 11, 2022
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review
Ambroise Lauby, Olivier Colomban, Pauline Corbaux, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2018
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients
Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, et al.
Cancer Chemotherapy and Pharmacology
|
February 25, 2023
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors
Romain Varnier, Alicja Puszkiel, Michel Tod, et al.
The American Journal of Surgical Pathology
|
November 19, 2025
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants
Alexis Trecourt, Clémence Scard, Françoise Descotes, et al.
BMC Pharmacology & Toxicology
|
January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factors
Marie Parel, Florence Ranchon, Audrey Nosbaum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2025
Utility of CA125 KELIM in predicting benefit from hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer: pooled analysis of KGOG3042 and KOV-HIPEC-01
Hyun-Woong Cho, Suk-Joon Chang, Myong Cheol Lim, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
BMC Research Notes
|
July 5, 2015
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods
Aurélie Bourmaud, Emilie Henin, Fabien Tinquaut, et al.
Cancer Chemotherapy and Pharmacology
|
January 8, 2022
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
Manon Reda, Pauline Macaire, Hélène Bellio, et al.
Gynecologic Oncology
|
February 6, 2026
Eco-responsible and rational interval debulking surgery for high-grade ovarian carcinomas: An observational, ambispective cohort study
Sarah Hodent, Naoual Bakrin, Pascal Rousset, et al.
Cancer Chemotherapy and Pharmacology
|
April 3, 2023
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial
Alicja Puszkiel, Benoit You, Léa Payen, et al.
Cancers
|
January 11, 2022
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review
Ambroise Lauby, Olivier Colomban, Pauline Corbaux, et al.
Cancer Chemotherapy and Pharmacology
|
June 28, 2018
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients
Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, et al.
Cancer Chemotherapy and Pharmacology
|
February 25, 2023
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors
Romain Varnier, Alicja Puszkiel, Michel Tod, et al.
The American Journal of Surgical Pathology
|
November 19, 2025
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants
Alexis Trecourt, Clémence Scard, Françoise Descotes, et al.
BMC Pharmacology & Toxicology
|
January 15, 2014
Hypersensitivity to oxaliplatin: clinical features and risk factors
Marie Parel, Florence Ranchon, Audrey Nosbaum, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2025
Utility of CA125 KELIM in predicting benefit from hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer: pooled analysis of KGOG3042 and KOV-HIPEC-01
Hyun-Woong Cho, Suk-Joon Chang, Myong Cheol Lim, et al.
Page
of 15